New IMI project “GNA NOW” kicks off its battle against antimicrobial resistance
05-Aug-2019 -
Evotec SE and Lygature announced their cooperation in a new initiative for the development of novel antibacterialagents: Gram-Negative Antibacterials NOW (“GNA NOW”). The new GNA NOW project, led by Evotec SE, managed by Lygature and funded by the Innovative Medicines Initiative (IMI), will work ...
antibacterial agents
antimicrobial resistance
drug development
+2